Pillstats
Rx only · Tablet, Film Coated · Oral

Amlodipine Valsartan And Hydrochlorothiazide

Brands: Amlodipine, Valsartan And Hydrochlorothiazide · Exforge Hct · Amlodipine,valsartan And Hydrochlorothiazide · Amlodipine Besylate + Hydrochlorothiazide + Valsartan

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)5487
US makers4 labelers
Packages35
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.31$8.62$12.94$17.25Jan 2025Mar 2026Jul 2026
$6.584
Latest avg · Jul 22, 2026
-56%
Since Jan 14, 2025
4
Active US suppliers
86%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.2K2.4K3.6K4.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.2K
Rx · 2026 Q1
227K
Units dispensed
+5681%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown15SUPPLYING
Macleods Pharmaceuticals Limitedunknown15SUPPLYING
Novartis Pharmaceuticals Corporationunknown5SUPPLYING
Lupin Pharmaceuticals,Inc.unknown0SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.